What is Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) share price return in the past 10 years?

Biofil Chemicals & Pharmaceuticals Ltd share price has appreciated 15.6% annually (CAGR) over the past ten years.

What is the share price of Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM)?

Company share prices are keep on changing according to the market conditions. The current trading price of Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) on 04-Jun-2026 16:59:59 at 16:59 is 34.45.

What is the P/E ratio of Biofil Chemicals & Pharmaceuticals?

The latest standalone P/E ratio of Biofil Chemicals & Pharmaceuticals as of 04-Jun-2026 is 20.12.

What is the P/B ratio of Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM)?

The latest standalone P/B ratio of Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) as of 04-Jun-2026 is 3.15.

What is the 52-week high and low of Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM)?

The 52-week high of Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) is Rs. 56.36 and the 52-week low is Rs. 25.60.

Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM)
Brand: Biofil Chemicals & Pharmaceuticals

Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524396 NSE: BIOFILCHEM Trading | Small Cap | Biofil Chem & Pharma Share Price

Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524396 NSE: BIOFILCHEM Trading | Small Cap | Biofil Chem & Pharma Share Price

Key Metrics

Valuation Multiples

Market Cap

₹56 Cr.

Current Price

₹34.5

52-Week Low / High

₹26 / 56

TTM EPS

₹1.7

TTM Sales

₹28.4 Cr.

Book Value per Share

₹10.9

P/E Ratio

20.12

Lower than its 5-year historical median

Industry PE

Price to Book (P/B)

3.15

Lower than its 5-year historical median

Price to Sales (P/S)

1.97

Lower than its 5-year historical median

EV/EBITDA

14.94

Lower than its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

3.02%

Outperforms industry median

Return on Capital Employed (ROCE)

4.08%

Outperforms industry median

Return on Assets (ROA)

1.14%

Operating Profit Margin

2.5%

Net Profit Margin

1.67%

Gross Profit Margin

3.3%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-16.58%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

3.66%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

-21.13%

Asset Quality

Promoter Holding

46.79%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹2 Cr.

Equity

₹16.3 Cr.

Face Value

₹10

All Time Low / High

₹0.30 / 352.45

Biofil Chemicals & Pharmaceuticals stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Biofil Chemicals & Pharmaceuticals Ltd a good quality company?

Biofil Chemicals & Pharmaceuticals Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Biofil Chemicals & Pharmaceuticals Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Biofil Chemicals & Pharmaceuticals Ltd vs industry peers?

Biofil Chemicals & Pharmaceuticals Ltd revenue CAGR is 2.38%, compared to the industry median CAGR of 0%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Biofil Chemicals & Pharmaceuticals Ltd?

Promoters hold 46.79% of the Biofil Chemicals & Pharmaceuticals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Biofil Chemicals & Pharmaceuticals Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 14.4% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	14%	21.9%	5.1%	5.1%	10.1%	12.2%	6.2%	4.8%	5%	4.1%	-
Value Creation Index ⓘ	0	0.6	-0.6	-0.6	-0.3	-0.1	-0.6	-0.7	-0.7	-0.7	-
Growth Parameters ⓘ
Sales ⓘ	13.2	13.5	12.4	23.1	29.7	35.8	22.4	30	40	33.4	28
Sales YoY Gr.	-	2.1%	-8.1%	87.1%	28.4%	20.4%	-37.4%	34.2%	33.3%	-16.6%	-
Adj EPS ⓘ	0.5	1.1	0.3	0.3	0.7	0.8	0.4	0.3	0.4	0.3	1.7
YoY Gr.	-	129.2%	-73.6%	3.5%	146.7%	2.7%	-43.4%	-20.9%	29.4%	-22.7%	-
BVPS (₹) ⓘ	4.4	7.8	8.1	8.4	9.2	9.9	10.4	10.6	11.2	11.5	10.9
Adj Net Profit ⓘ	0.8	1.8	0.5	0.5	1.2	1.2	0.7	0.6	0.7	0.6	3
Cash Flow from Ops. ⓘ	0.1	0.7	0.5	1.3	0.9	1.1	-0.2	-0.1	2.4	-1.9	-
Debt/CF from Ops. ⓘ	10	2	3.4	1.3	1.3	0.4	-2.1	-4.7	0.2	-0.3	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	10.9%	2.4%	14.3%	-16.6%
Adj EPS ⓘ	-3.8%	-14.4%	-7.5%	-22.7%
BVPSⓘ	11.3%	4.8%	3.7%	3.1%
Share Price	15.6%	-13.2%	-8%	-37.2%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	8.1	15.2	3.6	3.6	8.5	8	4.2	3.3	4	3	15.2
Op. Profit Mgn % ⓘ	6.6	19.5	7.6	4.4	6.1	4.5	6	3.9	2	2.5	2.3
Net Profit Mgn % ⓘ	5.9	13.3	3.8	2.1	4.1	3.5	3.1	1.9	1.8	1.7	9.8
Debt to Equity ⓘ	0.2	0.1	0.1	0.1	0.1	0	0	0	0	0	0
Working Cap Days ⓘ	271	371	397	223	282	281	262	192	267	429	187
Cash Conv. Cycle ⓘ	43	31	139	68	51	65	74	101	76	102	70

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	13.17	13.45	12.36	23.13	29.69	35.75	22.38	30.04	40.04	33.40
Operating Expenses ⓘ +	12.30	10.83	11.42	22.11	27.87	34.15	21.05	28.87	39.22	32.55
Manufacturing Costs	0.85	0.91	0.48	0.58	1.04	0.59	0.45	0.49	0.69	0.56
Material Costs	10.52	8.51	9.77	19.99	25.31	32.43	19.46	27.42	37.51	30.85
Employee Cost	0.48	0.53	0.73	0.89	0.86	0.75	0.79	0.45	0.50	0.61
Other Costs ⓘ	0.44	0.88	0.45	0.64	0.65	0.38	0.35	0.51	0.53	0.54
Operating Profit ⓘ	0.87	2.62	0.94	1.02	1.82	1.60	1.33	1.17	0.82	0.85
Operating Profit Margin (%)	6.6%	19.5%	7.6%	4.4%	6.1%	4.5%	6.0%	3.9%	2.0%	2.5%
Other Income ⓘ +	0.53	0.14	0.10	0.10	0.17	0.80	0.15	0.10	0.49	0.31
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0.15	0.16	0.15	0.16	0.12	0.07	0.04	0.04	0.04	0.04
Depreciation ⓘ	0.26	0.28	0.30	0.37	0.41	0.41	0.43	0.43	0.40	0.38
Profit Before Tax ⓘ	0.98	2.31	0.59	0.60	1.46	1.92	1.01	0.79	0.87	0.74
Tax ⓘ	0.20	0.52	0.12	0.12	0.26	0.68	0.32	0.23	0.16	0.18
Profit After Tax	0.78	1.79	0.47	0.48	1.21	1.24	0.70	0.56	0.71	0.56
PAT Margin (%)	5.9%	13.3%	3.8%	2.1%	4.1%	3.5%	3.1%	1.9%	1.8%	1.7%
Adjusted EPS (₹)	0.5	1.1	0.3	0.3	0.7	0.8	0.4	0.3	0.4	0.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Biofil Chem & Pharma - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	10.91	12.70	13.17	13.65	14.88	16.13	16.84	17.30	18.20	18.78
Share Capital ⓘ	16.27	16.27	16.27	16.27	16.27	16.27	16.27	16.27	16.27	16.27
Reserves ⓘ	-5.37	-3.58	-3.11	-2.62	-1.39	-0.14	0.56	1.03	1.93	2.51
Debt +	1.37	1.43	1.56	1.64	1.19	0.43	0.46	0.52	0.44	0.47
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	1.37	1.43	1.56	1.64	1.19	0.43	0.46	0.52	0.44	0.47
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	11.59	7.10	9.14	8.58	25.92	15.85	0.60	12.65	27.55	30.99
Others Liabilities ⓘ	0.26	0.62	0.29	0.34	0.37	0.83	0.83	0.93	0.89	0.72
Total Liabilities ⓘ	24.13	21.84	24.15	24.21	42.36	33.24	18.73	31.41	47.08	50.96
Fixed Assets
Net Fixed Assets ⓘ +	8.98	9.16	9.25	10.29	10.09	9.78	9.42	9	8.62	8.34
Gross Block	11.04	9.45	9.83	11.24	11.45	11.55	11.62	11.63	11.65	11.75
Accumulated Depreciation	2.06	0.29	0.58	0.95	1.36	1.77	2.20	2.63	3.03	3.41
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	0.10	0.17	1.02	1.19	1.69	4.34	1.29	1.21	2.55	3.34
Trade Receivables	13.98	11.46	12.98	12.03	29.71	17.22	7.17	20.50	33.03	38.32
Cash Equivalents	0.18	0.31	0.37	0.14	0.26	0.44	0.14	0.04	2.28	0.26
Others Assets ⓘ	0.89	0.74	0.53	0.57	0.62	1.46	0.70	0.65	0.60	0.70
Total Assets ⓘ	24.13	21.84	24.15	24.21	42.36	33.24	18.73	31.41	47.08	50.96

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	0.14	0.71	0.46	1.26	0.89	1.11	-0.22	-0.11	2.39	-1.92
PBT ⓘ	0.98	2.31	0.59	0.60	1.46	1.92	1.01	0.79	0.87	0.74
Adjustment ⓘ	0.42	0.45	0.45	0.53	0.56	0.48	0.48	0.38	0.63	0.44
Changes in Working Capital ⓘ	-0.96	-1.84	-0.07	0.25	-0.87	-0.62	-1.4	-1.05	1.05	-2.92
Tax Paid ⓘ	-0.15	-0.20	-0.50	-0.11	-0.25	-0.68	-0.32	-0.23	-0.16	-0.18
Cash Flow From Investing Activity ⓘ +	-0.19	-0.48	-0.38	-1.41	-0.21	-0.10	-0.07	-0.01	-0.02	-0.10
Capex	-0.19	-0.48	-0.38	-1.41	-0.21	-0.10	-0.07	-0.01	-0.02	-0.10
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	0	0	0
Cash Flow From Financing Activity ⓘ +	0.10	-0.11	-0.02	-0.08	-0.57	-0.83	-0.01	0.02	-0.12	-0
Net Proceeds from Shares ⓘ	1.71	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	-0.16	-0.15	-0.16	-0.12	-0.07	-0.04	-0.04	-0.04	-0.04
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	-1.61	0.06	0.13	0.08	-0.45	-0.76	0.03	0.06	-0.08	0.03
Net Cash Flow ⓘ	0.05	0.13	0.06	-0.24	0.12	0.18	-0.30	-0.11	2.25	-2.03

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	13.28	18.09	3.64	3.6	8.46	8.01	4.24	3.28	4	3.02
ROCE (%)	14.04	21.86	5.13	5.06	10.12	12.18	6.23	4.76	4.97	4.08
Asset Turnover Ratio	0.7	0.59	0.54	0.96	0.89	0.95	0.86	1.2	1.02	0.68
PAT to CFO Conversion(x)	0.18	0.4	0.98	2.63	0.74	0.9	-0.31	-0.2	3.37	-3.43
Working Capital Days
Receivable Days	244.40	345.20	360.90	197.30	256.50	239.60	198.90	168.20	244	389.80
Inventory Days	3.60	3.60	17.60	17.50	17.70	30.80	46	15.20	17.20	32.20
Payable Days	237.70	400.70	303.30	161.80	248.80	235.10	154.30	88.20	195.60	346.40

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Biofil Chemicals & Pharmaceuticals Ltd FAQs

The current trading price of Biofil Chem & Pharma on 04-Jun-2026 16:59 is ₹34.45.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Biofil Chem & Pharma stood at ₹56.06 Cr

The latest P/E ratio of Biofil Chem & Pharma as of 03-Jun-2026 is 20.12.

The latest P/B ratio of Biofil Chem & Pharma as of 03-Jun-2026 is 3.15.

The 52-week high of Biofil Chem & Pharma is ₹56.36 and the 52-week low is ₹25.60.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Biofil Chem & Pharma is ₹28.39 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Biofil Chemicals & Pharmaceuticals Ltd is a below average quality company.

The key valuation ratios of Biofil Chemicals & Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Biofil Chemicals & Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Biofil Chemicals & Pharmaceuticals Ltd

Biofil Chemicals & Pharmaceuticals established in 1985, is part of Cyano Group of Industries. The company is into manufacturing of drugs in area of anti-bacterial, analgesics/antipyretics, anti-malarial, anti-psychotics, anti asthmatic/bronchodilators, diuretics, tranquilizer/hypnotics, anti inflammatory, analgesic/antipyretics, anti inflammatory steroids and eye/ear drops

Its plant is located at Plot No. 8, Sector-IV Kheda Industrial Estate, Pithampur, Dhar District, Madhya Pradesh. The facility has received GMP certificate from Licensing Authority, Food & Drugs Administration, Department of Health and Government of Madhya Pradesh, India.

The manufacturing unit exports around 30 to 40% of their formulation directly or through merchant export to countries in own or neutral labels.

The shares of companies are listed on Bombay Stock Exchange.

Company exports its products to countries namely Kenya, Uganda, Tanzania, Nigeria, U.A.E, Rwanda, Monrovia, Republic of Yemen and Mauritius.

Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM)

Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM)

Biofil Chemicals & Pharmaceuticals stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Biofil Chem & Pharma - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Biofil Chemicals & Pharmaceuticals Ltd FAQs

About Biofil Chemicals & Pharmaceuticals Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM)

Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM)

Biofil Chemicals & Pharmaceuticals stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Biofil Chem & Pharma - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Biofil Chemicals & Pharmaceuticals Ltd FAQs

What is the share price of Biofil Chem & Pharma?

What is the market cap of Biofil Chem & Pharma?

What is the P/E ratio of Biofil Chem & Pharma?

What is the P/B ratio of Biofil Chem & Pharma?

What is the 52-week high and low of Biofil Chem & Pharma?

What is the TTM revenue of Biofil Chem & Pharma?

Is Biofil Chemicals & Pharmaceuticals Ltd a good quality company?

Is Biofil Chemicals & Pharmaceuticals Ltd undervalued or overvalued?

Is Biofil Chemicals & Pharmaceuticals Ltd a good buy now?

About Biofil Chemicals & Pharmaceuticals Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.